Trial Profile
A single arm, open label study to assess the efficacy, safety, and tolerability of monthly administration of RO0503821 for the treatment of chronic renal anaemia in patients not on dialysis and not currently treated with ESA.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Roche
- 08 May 2018 New trial record